NewsBenzinga武田公布3期数据：每日一次口服扎索替尼布在第16周实现PASI 100的比例为36.5%，高于德克拉维替尼的13.9%；实现PASI 90的比例为62.5%，高于34.0%；目前正接受FDA和EMA对斑块型银屑病的审评 武田公布3期数据：每日一次口服扎索替尼布在第16周实现PASI 100的比例为36.5%，高于德克拉维替尼的13.9%；实现PASI 90的比例为62.5%，高于34.0%；目前正接受FDA和EMA对斑块型银屑病的审评 Benzinga 2026.09.30 06:52 (GMT+0) Open on Benzinga Other news What to Expect From Fifth Third Bancorp's Q3 2026 Earnings Report Petrovietnam Unit BSR Signs ExxonMobil Asia-Pacific Crude Supply Agreement Ensuring Minimum 2M Barrels Yearly For Dung Quat Refinery, Alongside Chevron Framework Pact DoorDash Expands India Footprint With Hyderabad Global Tech Hub, Adding To Pune Office, And Plans 3,000 Jobs Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review BA Stock Climbs After Boeing Secures $20 Billion Contract as Pentagon Pushes Next-Generation Carrier Fighter Program After Years of Delays Victory Capital Holdings: Multiple Pillars Of Growth (NASDAQ:VCTR)
Petrovietnam Unit BSR Signs ExxonMobil Asia-Pacific Crude Supply Agreement Ensuring Minimum 2M Barrels Yearly For Dung Quat Refinery, Alongside Chevron Framework Pact
DoorDash Expands India Footprint With Hyderabad Global Tech Hub, Adding To Pune Office, And Plans 3,000 Jobs
Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review
BA Stock Climbs After Boeing Secures $20 Billion Contract as Pentagon Pushes Next-Generation Carrier Fighter Program After Years of Delays
